The next-generation ‘omics engine

Simplify Genomics was founded to address one of the most significant challenges in precision medicine: transforming the vast complexity of genomic data into clinically meaningful insights.

The company’s roots trace back to Human Longevity, Inc. (HLI), where members of the founding team developed large-scale genomic analysis and clinical reporting capabilities. Through years of experience supporting whole genome sequencing programs, the team recognized the need for a more scalable, accessible, and intelligent approach to genomic interpretation and exploration.

Building on this foundation, Simplify Genomics was created to combine clinical-grade genomic reporting with powerful genome-scale search and analysis technologies. Today, the company supports healthcare organizations, researchers, and precision medicine programs through Smart Genome™, a platform designed to make genomic data easier to interpret, explore, and apply in real-world clinical and research settings.

At Simplify Genomics, we believe the future of healthcare depends on making genomic information more accessible, actionable, and impactful for clinicians, researchers, and patients alike.